Sign Up to like & get
recommendations!
1
Published in 2018 at "Neuropsychopharmacology"
DOI: 10.1038/s41386-018-0285-4
Abstract: There has been considerable interest in the development of dopamine D3 receptor (DRD3) partial agonists and antagonists for the treatment of substance use disorders. Pre-clinical evidence overwhelmingly supports the use of these drugs, but translation…
read more here.
Keywords:
novel partial;
bp1;
bp1 4979;
agonist bp1 ... See more keywords